Target intelligence / Profile preview

Multiple Plasmodium proteins and heme

Molecular classification
Enzyme, Transporter, Other (heme/protein complex)
01

Overview

The entry "Multiple Plasmodium proteins and heme" does not refer to a single canonical molecular target but rather to a collection of parasite proteins (especially enzymes involved in hemoglobin degradation and heme detoxification) and the heme molecule itself, together forming the malaria parasite’s heme detoxification pathway. During the intraerythrocytic stage, Plasmodium species degrade host hemoglobin, releasing toxic free heme, which must be efficiently detoxified to allow parasite survival. This is chiefly achieved via conversion to the inert crystal hemozoin in the parasite's food vacuole, a process involving a multi-enzyme complex that includes falcipain-2/2', plasmepsins, histo aspartic protease, heme detoxification protein, and possibly other ancillary proteins[2][4][7]. Heme and its subsequent sequestration as hemozoin have been central targets for some of the most effective antimalarial drugs, including chloroquine and artemisinin, which act by inhibiting heme polymerization or binding free heme, causing toxic build-up to the parasite[2][4]. Due to the plurality of proteins and chemical entities involved, and the fact that "multiple Plasmodium proteins and heme" describes a pathway (not a single molecular target), this entry is considered non-canonical and should be refined for structured data or drug-target mapping purposes.

Other names
Plasmodium heme detoxification pathwayPlasmodium hemoglobin degradation proteinsPlasmodium hemozoin formation pathway
02

Mechanism of action

Inhibition of hemozoin formation, disruption of heme detoxification, inhibition of hemoglobin degradation

03

Biological functions

Hemoglobin degradationHeme detoxificationCell survival (parasite)Other (hemozoin formation)
04

Disease associations

Infection (malaria)
05

Safety considerations

Resistance to heme-targeting drugs (notably chloroquine and related compounds)Non-specific toxicity if host or off-target heme pathways are affected
06

Interacting drugs

Chloroquine

2 more in the full profile.

07

Biomarkers

Hemozoin (for monitoring parasite killing and drug efficacy)

Beyond the preview

Go deeper on Multiple Plasmodium proteins and heme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple Plasmodium proteins and heme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call